KannaSwiss AG, a Kölliken Switzerland-based supplier of top-tier CBD isolate products in Europe, raised $5.5m in funding.
Altitude Investment Management, plc (AIM plc), made the investment.
The company intends to use trhe funds to materially scale its commercial ethanol extraction operations both in bulk sales of CBD isolate and distillate, as well as in the development, marketing and sales of branded products.
KannaSwiss will fund additional production capabilities and biomass intake to meet its customer demand and accelerate attainment of ISO 9000 and GMP certification.
Founded in 2014 by Ivan Enderli and led by Chief Executive Officer Boris Blatnik, KannaSwiss is a top supplier of high-quality bulk CBD isolate and distillate throughout Europe. The company also markets a wide variety of other trusted CBD-based products, such as hemp oil, tinctures, creams, cosmetics and other CBD/wellness products.
The company has three main divisions:
– Health & Wellness and Bulk Sales, which are active today; and
– a Medical division, which is under development through joint ventures.